Sweden's Diabetes Market will reach US$ 1.86 Billion in 2028 and expand at a CAGR of 4.26% from 2023 to 2028, according to the publisher. Diabetes is obtaining epidemic proportions, and digital health companies are fighting back with innovative solutions. According to World Diabetes Organization, diabetes presently affects 59.8 million individuals in Europe, which will rise to 73.8 million by 2040. Diabetes is currently one of the most critical emergencies in global health and shows an increasing prevalence in Sweden. The healthcare system of Sweden has taken a heavy toll due to diabetes, which could be due to the associated direct costs required for medical management. Nowadays, caring for people with Type 2 diabetes has expanded from including only GPs to involving RNs in the main workforce. In Sweden, PHCCs have diabetes-responsible GPs and RNs available in-house who have the overall responsibility for the care and treatment of people with T2DM. According to the publisher, the Sweden Market was US$ 1.45 Billion in 2022.The Sweden Diabetes Market was US$ 1.45 Billion in 2022
Type 2 diabetes is a heterogeneous disease in Sweden
Diabetes mellitus is recognized as an epidemic. The prevalence of type 2 diabetes is increasing dramatically in Sweden, with projections of even higher growth over the coming decades. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure are indications of the increasing usage of diabetic drugs. At any age, increasing weight raises the risk of type 2 diabetes. In people who are obese, type 2 diabetes is three to ten times more common than it is in people of average weight. Moreover, over the past decades, childhood-onset type 1 diabetes has been reported to be increasing in Sweden.Insulin Pen will grow at a High Rate and Capturing the Highest Market Share in the Coming Years
The Sweden Diabetes Market by the device is segmented into; SMBG, CGM, Insulin Pumps, and Insulin Pens. Insulin cartridges in reusable pens are an upgraded version of insulin vials. Significant types of insulin are manufactured in the form of cartridges, which makes them easily attainable. These devices have all the functional advantages of reusable pens and are economical, as these cartridges are less costly than disposable insulin pens in the long run. Due to the rising demand for insulin cartridges, most insulin device manufacturers have produced reusable insulin pens compatible with various manufacturers' cartridges. These insulin cartridges are more consumer-friendly, as they are smaller and less observable than the classic vial-and-syringe. These devices are also more portable for consumers on the go.Moreover, the SMBG segment also holds a significant market share. Driving factors that help to reach this market are the increasing diabetic population in Sweden, Governments, and NGOs' efforts to increase awareness, increasing per capita healthcare expenditure, and availability of reimbursements.
Key Players:
The major players competing in the Sweden Diabetes Market are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.In May 2021, Medtronic announced the CE Mark for expanded functionality of the company's In Pen smart insulin pen for multiple daily injections (MDI).
In May 2021, Medtronic secured European approvals for its Guardian 4 sensor. The Guardian 4 sensor can be either utilized as a standalone continuous glucose monitor or combined into Medtronic's insulin pumps and pens to add real-time glucose monitoring alongside insulin tracking.
The report titled “Sweden Diabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement), Insulin Pen (User, Types - Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies), Company (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, InsuletCorporation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Sweden Diabetes Industry.
Segments Market based on Devices
1. Continuous Glucose Monitoring (CGM)2. Self-Monitoring Blood Glucose (SMBG)
3. Insulin Pen
4. Insulin Pump
Sweden Diabetes Sub-Segment Analysis
1. Continuous Glucose Monitoring (CGM)
1. Glucose Sensor Market & Forecast2. CGM Transmitter Market & Forecast
3. CGM User
4. CGM Reimbursement
2. SMBG
1. Test Strips Market and Forecast2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement
3. Insulin Pen Market
1. Disposable Insulin Pen2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle Market
5. Insulin Pen Users
6. Reimbursement Policies
4. Insulin Pump Market
1. Insulin Pump Market2. Insulin Pump Users
3. Insulin Pump Products
4. Reimbursement Policies
All the 13 Companies Studied in the Report have been Studied from 3 Points
- Company Overview
- Recent Developments
- Financial Insight
Company Analysis
1. B. Braun Melsungen AG2. Eli Lilly and Company
3. Terumo Corporation
4. Becton, Dickinson (BD)
5. Novo Nardisk
6. Ypsomed AG
7. Medtronic
8. InsuletCororation
9. Abbott Laboratories
10. DarioHealth Crop
11. Dexcom, Inc
12. Roche Diagnostic
13. Tandem Diabetes Care
Table of Contents
1. Introduction2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Sweden Diabetes Market
6. Sweden Diabetes Population
6.1 Type 1 Diabetes
6.2 Type 2 Diabetes
7. Sweden Diabetes Market Share Analysis
7.1 By Types
8. Continuous Glucose Monitoring Market (CGM) - Market & Users
8.1 Sweden - CGM Market by Components
8.1.1 Glucose Sensor Market
8.1.2 CGM Transmitter Market
8.2 CGM User
8.3 Reimbursement Policies of CGM Devices in Sweden
9. Blood Glucose Device (SMBG) -Sweden Market & Users
9.1 Market
9.1.1 Type 1 Diabetes Market
9.1.2 Type 2 Diabetes Market
9.2 Test Strips Market
9.2.1 Type 1 Diabetes
9.2.2 Type 2 Diabetes
9.3 Lancet Market
9.3.1 Type 1 Diabetes
9.3.2 Type 2 Diabetes
9.4 Meter Market
9.4.1 Type 1 Diabetes
9.4.2 Type 2 Diabetes
9.5 Blood Glucose (SMBG) Users
9.5.1 Type 1 Diabetes
9.5.2 Type 2 Diabetes
9.6 Reimbursement Policies of Blood Glucose Devices in Sweden
10. Insulin Pen -Sweden Market & User Analysis
10.1 Insulin Pen Market
10.1.1 Disposable Insulin Pen Market
10.1.2 Reusable Insulin Pen Market
10.1.3 Smart Insulin Pen Market
10.2 Insulin Pen Needle Market
10.3 Insulin Pen User
10.3.1 Disposable Insulin Pen User
10.3.2 Reusable Insulin Pen User
10.3.3 Smart Insulin Pen User
10.4 Reimbursement Policies of Insulin Pen in Sweden
11. Insulin Pump - Sweden Market & Users
11.1 Insulin Pump Market
11.1.1 Type 1 Diabetes Market
11.1.2 Type 2 Diabetes Market
11.2 Insulin Pump User
11.2.1 Type 1 Insulin Pump User
11.2.2 Type 2 Insulin Pump User
11.3 Differentiation Points of Insulin Pump Products in Sweden
11.3.1 Animas Vibe
11.3.2 Medtronic 530G with Enlite
11.3.3 Insulet OmniPod
11.3.4 Tandem t: slim
11.3.5 Roche Accu-Chek Combo
11.4 Training Model for Patients & HCP - of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care
11.4.1 Medtronic
11.4.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
11.4.1.2 Training Model for HCP (HealthCare Professional)
11.5 Insulet Corporation
11.5.1 Training Structure for New Patients - Insulet Corporation
11.6 Animas Corporation
11.6.1 Training Modules for New Patients
11.6.2 Training Modules for HCP (Health Care Professional)
11.7 Tandem Diabetes Care
11.8 Reimbursement Policies Insulin Pump
12. Insulin Pen - Company Analysis
12.1 B. Braun Melsungen AG
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 Eli Lilly
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Terumo Corporation
12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue
12.4 BD
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Novo Nordisk A/S
12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue
12.6 Ypsomed AG
12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue
13. Insulin Pump - Company Analysis
13.1 Medtronic
13.1.1 Overview
13.1.2 Recent Developments
13.1.3 Revenue
13.2 Insulet Corporation
13.2.1 Overview
13.2.2 Recent Developments
13.2.3 Revenue
14. SMBG - Company Analysis
14.1 DarioHealth Corp
14.1.1 Overview
14.1.2 Recent Developments
14.1.3 Revenue
14.2 Abbott Laboratories
14.2.1 Overview
14.2.2 Recent Developments
14.2.3 Revenue
15. CGM - Company Analysis
15.1 Dexcom Inc
15.1.1 Overview
15.1.2 Recent Developments
15.1.3 Revenue
15.2 Roche
15.2.1 Overview
15.2.2 Recent Developments
15.2.3 Revenue
15.3 Tandem Diabetes Care
15.3.1 Overview
15.3.2 Recent Developments
15.3.3 Revenue
List of Figures:
Figure 01: Sweden - Diabetes Market (Billion US$), 2017 - 2022
Figure 02: Sweden - Forecast for Diabetes Market (Billion US$), 2023 - 2028
Figure 03: Sweden - Type 1 Diabetes Population (Thousand), 2017 - 2022
Figure 04: Sweden - Forecast for Type 1 Diabetes Population (Thousand), 2023 - 2028
Figure 05: Sweden - Type 2 Diabetes Population (Thousand), 2017 - 2022
Figure 06: Sweden - Forecast for Type 2 Diabetes Population (Thousand), 2023 - 2028
Figure 07: Sweden - Glucose Sensor Market (Million US$), 2017 - 2023
Figure 08: Sweden - Forecast for Glucose Sensor Market (Million US$), 2023 - 2028
Figure 09: Sweden - CGM Transmitter Market (Million US$), 2017 - 2023
Figure 10: Sweden - Forecast for CGM Transmitter Market (Million US$), 2023 - 2028
Figure 11: Sweden - CGM User (Thousand), 2017 - 2023
Figure 12: Sweden - Forecast for CGM User (Thousand),2023 - 2028
Figure 13: Sweden - Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 14: Sweden - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 15: Sweden - Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 16: Sweden - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 17: Sweden - Test Strips Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 18: Sweden - Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 19: Sweden - Test Strips Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 20: Sweden - Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 21: Sweden - Lancet Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 22: Sweden - Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 23: Sweden - Lancet Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 24: Sweden - Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 25: Sweden - Meter Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 26: Sweden - Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 27: Sweden - Meter Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 28: Sweden - Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 29: Sweden - Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 - 2022
Figure 30: Sweden - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 - 2028
Figure 31: Sweden - Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 - 2022
Figure 32: Sweden - Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 - 2028
Figure 33: Sweden - Disposable Insulin Pen Market (Million US$), 2017 - 2023
Figure 34: Sweden - Forecast for Disposable Insulin Pen Market (Million US$), 2023 - 2028
Figure 35: Sweden - Reusable Insulin Pen Market (Million US$), 2017 - 2023
Figure 36: Sweden - Forecast for Reusable Insulin Pen Market (Million US$), 2023 - 2028
Figure 37: Sweden - Smart Insulin Pen Market (Million US$), 2017 - 2023
Figure 38: Sweden - Forecast for Smart Insulin Pen Market (Million US$), 2023 - 2028
Figure 39: Sweden - Disposable Insulin Pen User (Thousand), 2017 - 2022
Figure 40: Sweden - Forecast for Disposable Insulin Pen User (Thousand), 2023 - 2028
Figure 41: Sweden - Reusable Insulin Pen User (Thousand), 2017 - 2022
Figure 42: Sweden - Forecast for Reusable Insulin Pen User (Thousand), 2023 - 2028
Figure 43: Sweden - Smart Insulin Pen User (Thousand), 2017 - 2022
Figure 44: Sweden - Forecast for Smart Insulin Pen User (Thousand), 2023 - 2028
Figure 45: Sweden - Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 - 2023
Figure 46: Sweden - Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 - 2028
Figure 47: Sweden - Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 - 2023
Figure 48: Sweden - Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 - 2028
Figure 49: Sweden - Insulin Pump Type 1 Users (Thousand), 2017 - 2022
Figure 50: Sweden - Forecast for Insulin Pump Type 1 Users (Thousand), 2023 - 2028
Figure 51: Sweden - Insulin Pump Type 2 Users (Thousand), 2017 - 2022
Figure 52: Sweden - Forecast for Insulin Pump Type 2 Users (Thousand), 2023 - 2028
Figure 53: B. Braun Melsungen AG - Global Revenue (Billion US$), 2017 - 2022
Figure 54: B. Braun Melsungen AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 55: Eli Lilly - Global Revenue (Billion US$), 2017 - 2022
Figure 56: Eli Lilly - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 57: Terumo Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 58: Terumo Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 59: BD - Global Revenue (Billion US$), 2017 - 2022
Figure 60: BD - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 61: Novo Nordisk A/S - Global Revenue (Billion US$), 2017 - 2022
Figure 62: Novo Nordisk A/S - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 63: Ypsomed AG - Global Revenue (Billion US$), 2017 - 2022
Figure 64: Ypsomed AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 65: Medtronic - Global Revenue (Billion US$), 2017 - 2022
Figure 66: Medtronic - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 67: Insulet Corporation - Global Revenue (Billion US$), 2017 - 2022
Figure 68: Insulet Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 69: DarioHealth Corp - Global Revenue (Billion US$), 2017 - 2022
Figure 70: DarioHealth Corp - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 71: Abbott Laboratories - Global Revenue (Billion US$), 2017 - 2022
Figure 72: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 73: Dexcom Inc - Global Revenue (Billion US$), 2017 - 2022
Figure 74: Dexcom Inc - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Roche - Global Revenue (Billion US$), 2017 - 2022
Figure 76: Roche - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 77: Tandem Diabetes Care - Global Revenue (Billion US$), 2017 - 2022
Figure 78: Tandem Diabetes Care - Forecast for Global Revenue (Billion US$), 2023 - 2028
List of Tables:
Table 01: Sweden - Diabetes Market Share by Type (Percent), 2017 - 2022
Table 02: Sweden - Forecast for Diabetes Market Share by Type (Percent), 2023 - 2028
Companies Mentioned
- B. Braun Melsungen AG
- Eli Lilly and Company
- Terumo Corporation
- Becton, Dickinson (BD)
- Novo Nardisk
- Ypsomed AG
- Medtronic
- InsuletCororation
- Abbott Laboratories
- DarioHealth Crop
- Dexcom, Inc
- Roche Diagnostic
- Tandem Diabetes Care
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | February 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1.45 Billion |
| Forecasted Market Value ( USD | $ 1.86 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Sweden |
| No. of Companies Mentioned | 13 |
